💊Bringing a groundbreaking therapy to market is only half the battle. Ensuring that patients can predictably access it is where the real commercial strategy lies. In a new feature, CoverMyMeds's Nicole Eckl breaks down why unpredictable market access is a commercial risk for pharma, highlighting: - The financial ripple effect of delayed or unpredictable access on portfolio valuation -Why traditional, reactive access strategies are failing in today's market. -Proactive mitigation steps forward-thinking organizations are taking early in the drug lifecycle Read the full analysis here: https://lnkd.in/g_u-CbMy #pharma #patientaccess #DrugCommercialization #marketaccess
